HFNC (heated humidified high-flow nasal cannula) has several advantages over low flow nasal cannula and nasal CPAP for neonatal respiratory support. HFNC provides better humidification, delivers a fixed level of oxygen, uses higher gas flow that generates positive pressure, and can be used immediately post-extubation or as initial support with similar efficacy and safety as other non-invasive options. Evidence supports its use as post-extubation support in preterm infants, where it has less nasal trauma and reduced risk of pneumothorax compared to nasal CPAP. Delivery room CPAP can also reduce the need for intubation, ventilation and surfactant in preterm infants with RDS when initiated within 6 hours.